Abstract
1. The cardiovascular and behavioural effects of cholinomimetic drugs injected through a cannula chronically implanted into a lateral cerebral ventricle were examined in unanaesthetized dogs.
2. Acetylcholine (ACh) (10-20 μg) produced an increase in arterial pressure and heart rate, the dogs became more alert, moved their heads, licked and swallowed and then became drowsy.
3. The responses to ACh were potentiated by intraventricular physostigmine (5 μg), were abolished by intraventricular atropine (100 μg) but were unaffected by intraventricular mecamylamine (250 μg). The responses to ACh were reproducible on any one day if injections were given again after a 30 min interval but tolerance developed when ACh was injected repeatedly over periods of several days.
4. Methacholine (40 μg) produced similar behavioural and cardiovascular effects to ACh but of a longer duration. The responses to methacholine were abolished by intraventricular atropine (100 μg).
5. Nicotine (20-60 μg) produced a biphasic cardiovascular response of an initial brief pressor response and tachycardia followed by a secondary increase in arterial pressure and heart rate which was greater in magnitude and duration. The secondary cardiovascular effects were associated with restlessness and vomiting.
6. The responses to nicotine were abolished by prior injection of mecamylamine (250 μg) but were unaffected by atropine (100 μg). The responses to nicotine were not reproducible if injections were repeated on the same day but could be again produced if a few days were allowed to elapse between injections.
7. An increased heart rate occurred during the pressor response to the cholinomimetic drugs but when a comparable pressor response was produced by intravenous infusion of noradrenaline in the same unanaesthetized dogs pronounced reflex bradycardia resulted.
8. The results indicate that the activation of both muscarinic and nicotinic cholinergic mechanisms leads to cardiovascular and behavioural effects in the conscious dog although the site of action and peripheral mechanisms have not been determined.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BHATTACHARYA B. K., FELDBERG W. Perfusion of cerebral ventricles: assay of pharmacologically active substances in the effluent from the cisterna and the aqueduct. Br J Pharmacol Chemother. 1958 Jun;13(2):163–174. doi: 10.1111/j.1476-5381.1958.tb00212.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BHAWE W. B. Experiments on the fate of histamine and acetylcholine after their injection into the cerebral ventricles. J Physiol. 1958 Feb 17;140(2):169–189. doi: 10.1113/jphysiol.1958.sp005925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dhawan K. N., Gupta G. P., Dixit K. S., Chandra O. An analysis of the central vasomoter action of tyramine. Arch Int Pharmacodyn Ther. 1965 May;155(1):122–125. [PubMed] [Google Scholar]
- Domino E. F. A role of the central nervous system in the cardiovascular actions of nicotine. Arch Int Pharmacodyn Ther. 1969 May;179(1):167–179. [PubMed] [Google Scholar]
- FELDBERG W., SHERWOOD S. L. Injections of drugs into the lateral ventricle of the cat. J Physiol. 1954 Jan;123(1):148–167. doi: 10.1113/jphysiol.1954.sp005040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LANG W., GERSHON S., HOLAN G. SOME ANTAGONISTS OF ATROPINE-LIKE PSYCHOTOMIMETICS. J Pharm Pharmacol. 1963 Dec;15:831–840. doi: 10.1111/j.2042-7158.1963.tb12888.x. [DOI] [PubMed] [Google Scholar]
- RYALL R. W. THE IDENTIFICATION OF ACETYLCHOLINE IN PRESYNAPTIC TERMINALS ISOLATED FROM BRAIN. Biochem Pharmacol. 1963 Sep;12:1055–1056. doi: 10.1016/0006-2952(63)90029-7. [DOI] [PubMed] [Google Scholar]
- Sinha J. N., Dhawan K. N., Chandra O., Gupta G. P. Role of acetylcholine in central vasomotor regulation. Can J Physiol Pharmacol. 1967 May;45(3):503–507. doi: 10.1139/y67-059. [DOI] [PubMed] [Google Scholar]
- Srimal R. C., Jaju B. P., Sinha J. N., Dixit K. S., Bhargava K. P. Analysis of the central vasomotor effects of choline. Eur J Pharmacol. 1969 Feb;5(3):239–244. doi: 10.1016/0014-2999(69)90144-7. [DOI] [PubMed] [Google Scholar]